What is ORMP's P/E ratio?

Oramed Pharmaceuticals Inc (ORMP) currently trades at a P/E ratio of 1.51.

Oramed Pharmaceuticals Inc reports a Return on Equity (ROE) of 46.17%.

What is ORMP's dividend yield?

Oramed Pharmaceuticals Inc offers a dividend yield of 0.00%.

What is ORMP's Quality Score?

Our AI rates ORMP's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ORMP?

Our AI Timing Score for ORMP is 67 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ORMP belong to?

Oramed Pharmaceuticals Inc is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Oramed Pharmaceuticals Inc (ORMP) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

ORMP AI Analysis Summary

Our AI summary for ORMP: Oramed Pharmaceuticals Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 1.51, ROE of 46.17%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 67/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ORMP

Oramed Pharmaceuticals Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 81

USD 4.07

-0.05 (-1.21%) Day Change

Watchlist Portfolio Compare Chart

1.51

P/E

0.00

D/E

46.2%

ROE

40.9%

ROA

0.00%

Div Yield

ORAMED PHARMACEUTICALS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 4.07 Price -0.05 (-1.21%) Day Change	NEWS SCORE: 81

ORMP, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...

Loading chart...

62 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are ok , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

64%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	81
Magic Formula Rank by ROA	34 GREAT
Magic Formula Rank by ROE	34 GREAT
Magic Formula Rank by ROIC	54 GOOD
Price	4.07
PBV / Sector	0.70 / 5.20 GREAT
Earning Per Share	2.69

PE / Sector	1.51 / 19.97 GREAT
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	0.74 M GREAT
Average 1W Daily Value	0.55 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.71
NPM Average (%) / Sector	739.23 / -1,721.76 GREAT
NPM Change Average (%) / Sector	N/A / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	40.92 / 27.02 GREAT
ROA Average (%) / Sector	7.10 / -368.17
ROA Change Average (%) / Sector	-244.96 / 5,404.12
ROE (%) / Sector	46.17 / 3.47 GREAT
ROE Average (%) / Sector	8.73 / 6.51
ROE Change Average (%) / Sector	-225.59 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 08:00:17
Symbol	ORMP
Name	ORAMED PHARMACEUTICALS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	40.93 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	166.57 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1185 Avenue of the Americas, New York, NY, United States, 10036

Phone: 844 967 2633

Website: https://oramed.com

Sector: Healthcare >> Biotechnology

Description: Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.